Camila Lyon
Chief Investment Officer
Replay available
Curaleaf Holdings, Inc. (TSX: CURA) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Chief Investment Officer
Chairman and Chief Executive Officer
Chief Financial Officer
Analyst, Canaccord
Analyst, Econ Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Curaleaf Holdings, Inc..
WEBVTT 00:00:00.031 -- 00:00:02.774 Good day, and welcome to the CuraLeak Holdings, Inc. 00:00:02.774 -- 00:00:07.840 first quarter 2025 conference call. All participants will be in listen-only 00:00:07.840 -- 00:00:12.125 mode. Should you need assistance, please signal a conference specialist by pressing the 00:00:12.125 -- 00:00:17.271 star key followed by zero. After today's presentation, there will be an opportunity 00:00:17.271 -- 00:00:22.437 to ask questions. To ask a question, you may press star, then one on a touch-tone 00:00:22.437 -- 00:00:26.923 phone. To withdraw your question, please press star and then two. 00:00:26.923 -- 00:00:31.947 Please note this event is being recorded. I would now like to turn the conference 00:00:31.947 -- 00:00:34.752 over to Camila 00:00:34.752 -- 00:00:38.500 Lyon, Chief Investment Officer. Please go ahead. 00:00:38.500 -- 00:00:43.791 Good afternoon, everyone, and welcome to Cure Leap Holding's first quarter 2025 00:00:43.791 -- 00:00:49.121 conference call. Today, I'm joined by Chairman and Chief Executive Officer, Boris Jordan, 00:00:49.121 -- 00:00:54.380 and Chief Financial Officer, Ed Kremer. Before we begin, I'd like to remind everyone 00:00:54.380 -- 00:00:57.964 that the comments on today's call will include forward-looking statements within the 00:00:57.964 -- 00:01:02.748 meaning of the Canadian and United States securities laws, which by their nature involve 00:01:02.748 -- 00:01:07.773 estimates, projections, plans, goals, forecasts, and assumptions, including the successful 00:01:07.773 -- 00:01:12.037 integration of acquisitions and are subject to risks and uncertainties that could cause 00:01:12.037 -- 00:01:16.301 actual results or outcomes to differ materially from those expressed in the forward-looking 00...